PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12611085

Angiogenesis in hematologic malignancies.

R M Mesters
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Endothelial Growth FactorsHematologic NeoplasmsHumansIntercellular Signaling Peptides and ProteinsLymphokinesNeovascularization, PathologicVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth FactorsJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R M Mesters. 2002. Angiogenesis in hematologic malignancies.. https://pubmed.ncbi.nlm.nih.gov/12611085/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer.

Lysophosphatidic acid (LPA) receptors including LPA(1), LPA(2), and LPA(3) mediate lysophosphatidic acid signals. We analyzed the expression of LPA receptors, vascular endothelial growth factor (VEGF), and interleukin-8 in 97 patients from normal ovary to ovarian cancer, using reverse transcription polymerase chain reaction. LPA(2), LPA(3), and VEGF expression ratios significantly increased in cancer, compared to those in non-cancerous state (P<0.05). A significant correlation in the expression ratios between LPA(2) or LPA(3) and VEGF was found (gamma=0.617, P<0.0001; gamma=0.431, P<0.001) in patients with cancer. These results suggested that LPA(2) and LPA(3) may be involved in VEGF expression mediated by LPA signals in human ovarian oncogenesis.

Endothelial Growth Factors↗